Prostate cancer Board decisions

The Board has remanded the claim of service connection for prostate cancer due to exposure to Agent Orange, as it is unclear if the Veteran was exposed during his time in Okinawa, Japan. The RO needs to make updated requests to DPRIS regarding this potential exposure.

The Board has remanded the cases for further development due to insufficient evidence regarding service connection for prostate cancer, kidney disorder, and skin disorder as a result of exposure at Camp Lejeune.

The Veteran's service-connected disabilities have prevented them from obtaining or maintaining gainful employment, and the Board has granted a TDIU rating.

Service connection for hypertension and prostate cancer is granted. Service connection for peripheral neuropathy of the bilateral lower extremities and a heart condition (presumed ischemic heart disease) are remanded for further development.

The discontinuance of the 100 percent evaluation for prostate cancer was denied, as it was by operation of law.,The discontinuance of the 100 percent evaluation for lung cancer is remanded due to a lack of VA treatment records.

The Board denied the Veteran's claims for service connection for right knee disorder, prostate cancer, and bladder cancer. The evidence did not support a finding that these conditions were related to his active service or service-connected hepatitis C.

The Board has remanded the Veteran's claims for service connection for a prostate disability and an anal disability due to exposure to diesel fuel and/or paint thinner during service. Additional development is needed, including obtaining medical opinions on whether these conditions are causally or etiologically related to service.

The Board denied service connection for a heart disorder, prostate cancer, diabetes mellitus type II, left lower extremity neuropathy, right lower extremity neuropathy, and tinnitus as there was no evidence of in-service incurrence or chronicity.

The Board has remanded the case due to a pre-decisional duty-to-assist error regarding the Veteran's exposure to radiation during service, specifically x-rays without protective gear. The RO needs to seek out additional records and prepare a dose estimate based on available methodologies.

The Board has granted service connection for prostate cancer and urinary incontinence, but remanded the issue of service connection for erectile dysfunction.

The Veteran's claim for service connection for residuals of prostate cancer is granted due to the presumption of exposure to herbicide agents, as his duties placed him in close proximity to the DMZ during his service in Korea.

The Veteran's prostate cancer residuals have required changing absorbent material more than 4 times per day, qualifying for a 60 percent rating.

The Veteran's claim for service connection of prostate cancer is granted with an effective date of August 21, 2015.

The Veteran's claims for service connection for prostate cancer, erectile dysfunction as secondary to prostate cancer, and urinary frequency as secondary to prostate cancer have been denied. The Board found no evidence of herbicide exposure during service, and the Veteran does not meet the criteria for presumptive service connection due to his Vietnam-era service. Additionally, there is insufficient evidence to establish a link between the current conditions and service.

The Veteran's service-connected prostate cancer is linked to his current voiding residuals, erectile dysfunction, and unspecified anxiety disorder. The PACT Act of 2022 grants service connection for these conditions.

The Board has decided to remand the cases for further development and consideration due to potential additional residuals of prostate cancer not fully addressed by previous examinations.

The Veteran's service connection claims for prostate cancer, diabetes mellitus, and hypertension are granted. The Board has remanded the cases to determine if there is a causal relationship between these conditions and exposure to ionizing radiation during service.

The Board has remanded the Veteran's appeal for further development, including a VA examination by a urologist to differentiate between symptoms attributable to each of his service-connected genitourinary disabilities.

The Veteran's claims for service connection for achalasia, prostate cancer, and bilateral hearing loss are denied. The case is remanded for further action on the issue of bilateral hearing loss.

The Veteran's prostate cancer, erectile dysfunction, and voiding dysfunction are granted as secondary to exposure to herbicide agents. The Veteran's GERD is remanded for further examination.